All posts tagged: Drug Development

Day One Biopharmaceuticals

Day One Biopharmaceutical, a start-up biotech company founded with a focus on developing therapies for children with cancer through drug repurposing announced its debut in the market last week.  Its first agent, DAY101, licensed from Takeda Pharmaceuticals, is a targeted treatment for children with low grade glioma, a type of […]

Read more

Accelerating Drug Development for Children and Adolescents with Cancer

We were pleased to invite CAC2 members, associate members, student members, supporting organizations to our December CAC2 All-member webinar where Susan Weiner (Children’s Cancer Cause) hosted Dr. Gilles Vassal, chair of ACCELERATE, an international nonprofit. Dr. Vassal discussed ACCELERATE and its fresh approach to addressing the complex challenges of developing innovative pediatric cancer […]

Read more

Understanding and Enhancing the Role of Children with Cancer and their Parents in Pediatric Oncology Drug Development

This month’s webinar was presented by Stacy Crane, Predoctoral Fellow at Indiana University School of Nursing.  She described the experience of participating in a Phase I clinical trial from the perspective of the parents of children battling cancer. While overall, parents do not regret their child participating in a phase I clinical trial […]

Read more

Dr. Jeffrey Skolnik–Basics of Pediatric Drug Development–Slide Deck and Presentation Audio

On Wednesday, November 12, CAC2 had the privilege of hosting Jeffrey Skolnik, MD US Medical Affairs Leader, Oncology GlaxoSmithKline Attending Physician, Children’s Hospital of Philadelphia as he presented our November All-Member webinar about the industry perspective in pediatric oncology drug development.  By clicking on the presentation title below you can […]

Read more

Enquire now

Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.